Specialized Topics

Syndicate content Subscribe to this feed
PrintPrintEmail this pageEmail this page
Group homepage: 

Welcome to the Specialized Topics classroom. CME activities are available at no charge to registered users of the site. Not a registered user? Register now for free.

*Note: If you wish to be notified when new courses on specialized topics related to pulmonary hypertension are added, make sure you're logged-in and click "Subscribe" to the left.

To report technical issues, please email PHAOnlineUniv@PHAssociation.org 

Thoracic Transplantation for Pulmonary Arterial Hypertension

Credit type: 
Physician
Credit Hours: 
1.00
Activity Release Date: 
Dec 6 2010
Activity Expiration Date: 
Oct 31 2012

This course provides an overview of the current clinical landscape of lung transplantation for patients with pulmonary hypertension.

Pulmonary Hypertension in Systemic Sclerosis

Credit type: 
Physician
Credit Hours: 
1.00
Activity Release Date: 
Jan 27 2011
Activity Expiration Date: 
Oct 31 2013

Dr. Virginia Steen, a Professor of Medicine at Georgetown University specializing in rheumatology, and a member of the PHA
Scientific Leadership Council, presents a talk entitled "Pulmonary Hypertension(PH) in Systemic Sclerosis". We hope that you will enjoy this fascinating presentation by a leader in the field of PH. This course aims to help medical professionals identify the scleroderma patients at a high risk of developing PH, identify the different types of PH that affect scleroderma patients and to understand the PH medications, thier various side effects and when to make changes in the treatment of PH in Scleroderma.

Pulmonary Hypertension Associated with Obstructive Lung Disease and Hypoxemia (WHO Group III)

Credit type: 
Physician
Credit Hours: 
1.00
Activity Release Date: 
Apr 29 2011
Activity Expiration Date: 
Oct 31 2012

Explore the pathophysiology of Pulmonary Hypertension in lung disease as well as the clinical approach to evaluation and treatment of PH patients.

Genetics of Pulmonary Hypertension

Course Image: 
Credit type: 
Physician
Credit Hours: 
0.75
Activity Release Date: 
Oct 5 2011
Activity Expiration Date: 
Sep 1 2012

As part of the preceedings at the 4th Annual International Neonatal and Childhood Pulmonary Vascular Disease Conference, Nicholas Morrell presented this session on the genetic involvement in hereditary pulmonary hypertension.  Dr. Morrell discusses how the expression of the BMPR2 mutation affects the physiological progression of pulmonary hypertension.

Hepatopulmonary Sydrome

Course Image: 
Credit type: 
Physician
Credit Hours: 
0.50
Activity Release Date: 
Oct 5 2011
Activity Expiration Date: 
Sep 1 2012

At the 4th International Neonatal and Childhood Pulmonary Vascular Disease Conference, Stephen Archer, MD described the role for DC68(+) macrophages in the etiology of hepatopulmonary sydrome and how macrophage depletion can cause a reversal. This is especially relevant to pulmonary hypertension as this can transition to portopulmonary hypertension following liver transplantation.

Inducible Intrapulmonary Arteriovenous Shunt Pathways

Course Image: 
Credit type: 
Physician
Credit Hours: 
0.75
Activity Release Date: 
Oct 5 2011
Activity Expiration Date: 
Sep 1 2012

Marlowe Eldridge, MD presented this session at the 4th International Neonatal and Childhood Pulmonary Vascular Disease Conference.  In this recording Dr. Eldridge discusses how inducible intrapulmonary arteriovenous shunt pathways may challenge conventional wisdom.

Pulmonary Arteriovenous Malformations After the Bidirectional Glenn and the Role of Vascular Endothelial Growth Factor

Course Image: 
Credit type: 
Physician
Credit Hours: 
0.50
Activity Release Date: 
Oct 5 2011
Activity Expiration Date: 
Sep 1 2012

Narayanswami Sreeram, MD, presented this session on pulmonary arteriovenous malformations after the bidirectional glenn at the 4th International Neonatal and Childhood Pulmonary Vascular Disease Conference.  Dr. Sreeram also discusses the role of vascualr endothelial growth factor.

Emerging Pharmacological Treatment Approaches/Novel Pathways: Strengths, Gaps, Unmet Needs

Course Image: 
Credit type: 
Physician
Credit Hours: 
0.75
Activity Release Date: 
Jan 19 2012
Activity Expiration Date: 
Sep 1 2012

Dr. Robyn Barst discusses the future of pulmonary hypertension therapies in this presentation from the 4th International Neonatal and Childhood Pulmonary Vascular Disease Conference.  From tyrosine kinase inhibitors to inhaled nitrous oxide and the many opportunites for treatment currently under research.

Update on Eisenmenger Syndrome: The Role of Specific Pulmonary Hypertension Therapies

Course Image: 
Credit type: 
Physician
Credit Hours: 
0.50
Activity Release Date: 
Jan 19 2012
Activity Expiration Date: 
Sep 1 2012

Dr. Gary Webb gave this update on Eisenmenger Syndromes and the specific therapies related to pulmonary hypertension at the 4th International Neonatal and Childhood Pulmonary Vascular Disease Conference.  This presentation covers the definition and causes of Eisenmenger syndrome as well as issues involved with pulmonary artery banding.

Pulmonary Arterial Hypertension in Systemic Sclerosis: Characteristics and Diagnosis

Credit type: 
Physician
Credit Hours: 
0.75
Activity Release Date: 
Feb 2 2012
Activity Expiration Date: 
Oct 31 2013

Dr. Silver presents this course which will discuss the diagnosis of pulmonary arterial hypertension in systemic sclerosis.  This includes an overview of scleroderma and the classification criteria as well as predominant subtypes in scleroderma as well as a look at the causes of PAH in scleroderma patients.